• 1. Emerging investigator series: kinetics of diopside reactivity for carbon mineralization in mafic–ultramafic rocks
  BrianaAguila,LandonHardee,H.ToddSchaef,SiavashZare,MohammadJavadAbdolhosseiniQomi,JarrodV.Crum,JadeE.HollimanJr.,ElenaTajueloRodriguez,LawrenceM.Anovitz,KevinM.Rosso,QuinR.S.Miller
• 2. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 3. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 4. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 5. Distinct impact of glycation towards the aggregation and toxicity of murine and human amyloid-β?
  Eunju Nam,Jiyeon Han,Sunhee Choi,Mi Hee Lim Chem. Commun., 2021,57, 7637-7640

tert-butyl 1,7-diazaspiro[4.5]decane-7-carboxylate (CAS No. 939793-21-2): An Overview of Its Structure, Synthesis, and Applications in Medicinal Chemistry

tert-butyl 1,7-diazaspiro[4.5]decane-7-carboxylate (CAS No. 939793-21-2) is a versatile compound with significant potential in the field of medicinal chemistry. This compound, characterized by its unique spirocyclic structure and functional groups, has garnered attention for its role in the development of novel therapeutic agents and as a key intermediate in synthetic pathways.

The structure of tert-butyl 1,7-diazaspiro[4.5]decane-7-carboxylate consists of a spirocyclic framework with a tert-butyl ester group attached to the carboxylic acid moiety. The spirocyclic system, specifically the 1,7-diazaspiro[4.5]decane ring, provides a rigid and conformationally constrained scaffold that can influence the pharmacological properties of molecules derived from it. The tert-butyl ester group adds stability and can be selectively cleaved under mild conditions, making it an ideal protecting group in multistep synthetic sequences.

In terms of synthesis, tert-butyl 1,7-diazaspiro[4.5]decane-7-carboxylate can be prepared through a series of well-defined chemical transformations. One common approach involves the reaction of a suitable spirocyclic amine with a tert-butyl halide or anhydride to form the tert-butyl ester. Recent advancements in catalytic methods have further streamlined this process, allowing for higher yields and improved stereoselectivity. For instance, a study published in the Journal of Organic Chemistry reported the use of palladium-catalyzed cross-coupling reactions to efficiently synthesize this compound with high purity and yield.

The applications of tert-butyl 1,7-diazaspiro[4.5]decane-7-carboxylate are diverse and span multiple areas of medicinal chemistry. One notable application is its use as a building block in the synthesis of bioactive molecules targeting various therapeutic areas. For example, researchers at the University of California have utilized this compound to develop novel inhibitors of protein-protein interactions (PPIs), which are critical for modulating cellular signaling pathways involved in diseases such as cancer and neurodegenerative disorders.

Another significant application is in the field of central nervous system (CNS) disorders. The spirocyclic structure of tert-butyl 1,7-diazaspiro[4.5]decane-7-carboxylate has been shown to enhance blood-brain barrier permeability, making it an attractive scaffold for designing drugs that target neurological conditions. A recent study published in ACS Chemical Neuroscience demonstrated that derivatives of this compound exhibited potent activity against Alzheimer's disease by inhibiting beta-secretase (BACE1), an enzyme involved in the production of amyloid-beta peptides.

In addition to its therapeutic potential, tert-butyl 1,7-diazaspiro[4.5]decane-7-carboxylate is also valuable as a research tool in chemical biology. Its unique structural features allow it to serve as a probe for studying protein-ligand interactions and for identifying new biological targets. For instance, it has been used in high-throughput screening assays to identify small molecules that modulate specific cellular processes.

The pharmacological properties of tert-butyl 1,7-diazaspiro[4.5]decane-7-carboxylate and its derivatives have been extensively studied to understand their mechanisms of action and optimize their therapeutic profiles. In vitro studies have shown that these compounds exhibit selective binding to specific receptors or enzymes, leading to modulated biological responses. In vivo studies have further confirmed their efficacy and safety profiles, paving the way for clinical development.

The future outlook for tert-butyl 1,7-diazaspiro[4.5]decane-7-carboxylate is promising. Ongoing research aims to expand its applications by exploring new synthetic routes and developing more potent and selective derivatives. Collaborations between academic institutions and pharmaceutical companies are driving innovation in this area, with several compounds derived from this scaffold currently in preclinical and early clinical stages.

In conclusion, tert-butyl 1,7-diazaspiro[4.5]decane-7-carboxylate (CAS No. 939793-21-2) is a multifaceted compound with significant potential in medicinal chemistry and drug discovery. Its unique structural features and versatile synthetic accessibility make it an invaluable tool for researchers aiming to develop novel therapeutic agents and advance our understanding of complex biological systems.

• 960294-14-8(Tert-Butyl 1,7-diazaspiro[4.5]decane-1-carboxylate)
• 1305712-11-1(tert-butyl 4-(aminomethyl)-4-(pyrrolidin-1-yl)piperidine-1-carboxylate)
• 1086394-55-9(Tert-butyl 2,6-diazaspiro[4.5]decane-2-carboxylate)
• 1785258-09-4(tert-butyl 2-(aminomethyl)-2-methyl-piperidine-1-carboxylate)
• 1086394-76-4(2,6-Diazaspiro[4.5]decane-6-carboxylic acid, phenylMethyl ester)
• 2444880-45-7(Tert-butyl 1,7-diazaspiro[4.5]decane-1-carboxylate hydrochloride)
• 1391733-32-6(tert-butyl 6-ethyl-1,7-diazaspiro[4.5]decane-7-carboxylate)
• 960294-18-2(Tert-butyl 1,8-diazaspiro[5.5]undecane-1-carboxylate)
• 960294-16-0(tert-butyl 2,6-diazaspiro[4.5]decane-6-carboxylate)
• 2306275-37-4(tert-butyl 4-(tert-butoxycarbonylamino)-2-azabicyclo[2.2.2]octane-2-carboxylate)